Sunday, 1 October 2017

How New Generation Drugs Are Targeting Depression

an article by Therese J. Borchard for the World of Psychology blog

Two years ago, I talked with a prominent psychiatrist about what could be done for all the people who have treatment-resistant depression who do not respond – or only partially respond – to the drugs on the market today.

“We wait for better drugs to come out,” he said.

I wanted a better answer, because my experience with the newer drugs like Zyprexa (olanzapine) – atypical neuroleptics (a type of antipsychotic) that were supposed to treat bipolar disorder with fewer side effects than typical mood stabilizers like lithium and Depakote (divalproex sodium) – proved to be a disaster.

But I am coming around to agree with the psychiatrist.

Continue reading because apart from the information in the basic article by an acknowledged expert on depression there are lots of links to further information. I, luckily and happily, do not have treatment-resistant depression but can understand the difficulties experienced by those who have.






No comments: